Infertility and risk of fatal ovarian cancer in a prospective cohort of US women

Cancer Causes and Control

Volumn 9, Issue 6, 1998, Pages 645-651

  Rodriguez, Carmen ^a   Tatham, Lilith M ^a,b   Calle, Eugenia E ^a   Thun, Michael J ^a   Jacobs, Eric J ^a   Heath Jr , Clark W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b AGENCY FOR TOXIC SUBSTANCES AND DISEASE REGISTRY   (United States)

Author keywords

Cohort study; Infertility; Ovarian cancer; United States

Indexed keywords

FERTILITY PROMOTING AGENT;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; OVARY CANCER; PREGNANCY; PRIORITY JOURNAL; SELF REPORT; UNITED STATES;

ADULT; AGED; COHORT STUDIES; FEMALE; FERTILITY AGENTS, FEMALE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY; MIDDLE AGED; OVARIAN NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0032414177     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008845106869     Document Type: Article

References (30)

1. Whittemore AS, Harris R, Itnyre J, and the Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 case-control Studies. II. Invasive epithelial ovarian cancer in white women. Am J Epidemiol 1992; 136: 1184-1203.
2. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140: 585-97.
3. Cohen J, Forman R, Harlap S, Johannisson E, Lunenfeld B, De Mouzon J, et al. IFFS Expert Group Report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Human Reproduction 1993; 7: 996-9.
4. Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996; 65: 499-507.
5. Wysowski DK. Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril 1993; 60: 1096-8.
6. Kuljarni R, McGarry JM. Follicular stimulation and ovarian cancer. Br Med J 1989; 299: 740.
7. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br J Obstet Gynaecol 1982; 89: 962-4.
8. Spirtas R, Kaufman SC, Alexander NJ. Fertility drugs and ovarian cancer: red alert or red herring? Fertil Steril 1993; 59: 291-3.
9. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989; 49: 3670-4.
10. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-6.
11. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995; 346: 995-1000.
12. Ron E, Lunenfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125: 780-90.
13. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 1989; 60: 592-8.
14. Hartge P, Hoover R, McGowan L, Lesher L, Norris HJ. Menopause and ovarian cancer. Am J Epidemiol 1988; 127: 990-8.
15. Cramer DW, Hutchinson GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71: 711-6.
16. Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984; 119: 705-13.
17. Purdie D, Green A, Bain C, Siskind V, Ward B, Hacker N, et al. Reproductive and other factors and risk of epithelial ovarian cancer: an Australian case-control study. Int J Cancer 1995; 62: 678-84.
18. Brinton LA, Melton LJ III, Malkasian GD Jr, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129: 712-22.
19. Stellman SD, Garfinkel L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst 1986; 76: 1057-63.
20. Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 1993; 137: 235-41.
21. World Health Organization. International Classification of Diseases. Annual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Ninth Revision. Geneva: World Health Organization, 1979.
22. Pokras R. Hysterectomy: past, present and future. Statistical Bulletin 1989; Oct: 12-21.
23. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972; 34: 187-220.
24. Weiss NS. Measuring the separate effects of low parity and its antecedents on the incidence of ovarian cancer. Am J Epidemiol 1988; 128: 451-5.
25. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic Research: Principles and Quantitative Methods. New York: Van Nostrand Reinhold Co, 1982.
26. Rodriguez C, Calle EE, Coates RJ, Miracle-McMahill HL, Thun MJ, Heath CW Jr. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141: 828-35.
27. Templeton A. Infertility-epidemiology, aetiology and effective management. Health Bull 1995; 5: 294-98.
28. Ries LAG, Kosary CL, Hankey BF, Harras A, Miller BA, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1993: Tables and Graphs. Bethesda, MD: National Cancer Institute, 1996.
29. Mosher WD, Pratt WF. Fecundity and infertility in the United States: Incidence and trends. Fertil Steril 1991; 56: 192-3.
30. Infertility - United States, 1982. MMWR 1985; 34: 197-9.